Akaal Pharma
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
+44 2086796015Website
www.akaalpharma.comRevenue
$6.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Akaal Pharma
Akaal Pharma Pty Ltd is a clinical-stage drug discovery and development company dedicated to creating innovative therapies for inflammatory and autoimmune diseases. The company focuses on early-stage drug discovery, developing novel drug candidates that target significant medical needs with an emphasis on safety, efficacy, and affordability. Akaal Pharma aims to partner with organizations committed to advancing treatment solutions. Their mission is to transform the treatment landscape for these diseases through groundbreaking therapies.Explore more
Akaal Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Akaal Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Akaal Pharma is spiking on competitors!
Earning: See what the market has to say on Akaal Pharma recently announced quarterly report
Click to see if Akaal Pharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Akaal Pharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Akaal Pharma launches new products
Akaal Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Akaal Pharma
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Akaal Pharma has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Akaal Pharma
Compare insights from companies similar to Akaal Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Akaal Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Akaal Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Akaal Pharma.
Akaal Pharma Tech Stack
A closer look at the technologies used by Akaal Pharma
See more technologies
Akaal Pharma News & Media
Akaal Pharma: Positive Phase-2 Results for S1P1 Agonist in the Treatment of Atopic Dermatitis and Associated Pruritus
SHEPPARTON, VICTORIA, AUSTRALIA, June 10, 2025 /EINPresswire.com/ -- Akaal Pharma Pty Ltd Announces Positive Phase-2 Results for S1P1 Agonist in the Treatment of Atopic Dermatitis and Associated Pruritus A biopharmaceutical company focused on novel …Akaal Pharma has completed recruitment for a Phase-2 clinical trial for atopic dermatitis and associated pruritus
GREATER SHEPPARTON, VICTORIA, AUSTRALIA, June 5, 2024 /EINPresswire.com/ -- Akaal Pharma Pty Ltd has completed recruitment for a Phase-2 clinical trial involving patients with atopic dermatitis and associated pruritus. Akaal Pharma Pty Limited (Akaal) …Akaal Pharma Pty Ltd has received approval for a Phase-2 clinical trial involving patients with atopic dermatitis
AUSTRALIA, May 3, 2023 /EINPresswire.com/ -- Akaal Pharma Pty Ltd has received approval for a Phase-2 clinical trial involving patients with atopic dermatitis. Akaal Pharma Pty Limited (Akaal) today announced that it has received regulatory approval …Akaal Pharma Pty Ltd Announces Licensing Agreement for its First-in-Class, Topical Spingosine-1-Phosphate-1 (S1P1) Receptor Modulator for Atopic Dermatitis and Psoriasis
MELBOURNE, Australia--(BUSINESS WIRE)--Akaal Pharma Pty Limited (Akaal Pharma) today announced that it has entered into a licensing agreement for Akaal Pharma’s First-in-Class, topical Spingosine-1-Phosphate-1 (S1P1) modulator, AKP-11, with Boston Pharmaceuticals, Inc. (Boston Pharmaceuticals). AKP-11 is a differentiated S1P1 modulator, which potentially has clinical applications in a number of inflammatory, immune and vascular diseases. Akaal Pharma has demonstrated the clinical activity of AK
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Akaal Pharma
Sign Up For FreeTo access detailed company insights
Akaal Pharma Pty Ltd is a clinical-stage drug discovery and development company dedicated to creating innovative therapies for inflammatory and autoimmune diseases. The company focuses on early-stage drug discovery, developing novel drug candidates that target significant medical needs with an emphasis on safety, efficacy, and affordability. Akaal... Read More
